Americas

News and reports from North, Central and South America.

UBEO ACQUIRES CENTRIC BUSINESS SYSTEMS, EXPANDS TO MID-ATLANTIC

Presswire, 19 January 2022

UBEO Business Services (“UBEO”), one of the largest national providers of business technology and related services, is proud to announce that Centric Business Systems has joined the UBEO family of companies.

UBEO ACQUIRES CENTRIC BUSINESS SYSTEMS, EXPANDS TO MID-ATLANTIC

Presswire, 18 January 2022

UBEO Business Services (“UBEO”), one of the largest national providers of business technology and related services, is proud to announce that Centric Business Systems has joined the UBEO family of companies.

Rockridge Resources Reports 4.06% and 1.60% Copper in Grab Samples and Identifies New Target West of Gilbert Lake at its Knife Lake Project

Presswire, 18 January 2022

Rockridge Resources Ltd. (TSX-V: ROCK) (OTCQB: RRRLF) (Frankfurt: RR0) (“Rockridge” or the “Company”) is pleased to announce further sampling and prospecting results from the 2021 exploration program at the  Knife Lake Copper VMS Project located in Saskatchewan, Canada (the “Knife Lake Project” or “Property”). The Knife Lake Project, consisting of 82 claims totaling 56,865 hectares (140,516 acres), is an advanced-stage copper, silver, zinc and cobalt exploration property in Saskatchewan host to the Knife Lake Deposit.

ProMIS Neurosciences Announces Antibody Program for Schizophrenia Therapy and Recruitment of Dr. Carsten Korth to its Scientific Advisory Board

Presswire, 18 January 2022

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has initiated a program to develop monoclonal antibodies to treat schizophrenia and other chronic mental illnesses. Schizophrenia is a clinical term for a severely disabling neuropsychiatric disease that disrupts employment, families and communities, and likely has heterogenous biological origins.

Skyharbour’s Partner Company Azincourt Energy Provides Update on Camp Construction and Drill Mobilization at East Preston Uranium Project, Saskatchewan

Presswire, 13 January 2022

Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt Energy (“Azincourt”) is pleased to announce that construction of the exploration camp for the winter 2022 exploration program is underway at the East Preston uranium project, located in the western Athabasca Basin, Saskatchewan, Canada.

FOBI Announces Definitive Agreement To Acquire Passworks S.A. for €400,000 To Further Expand FOBI's Global Digital Wallet Pass Portfolio

Presswire, 13 January 2022

FOBI AI Inc. (TSXV: FOBI, OTCQB: FOBIF) (the "Company" or "FOBI"), a global leader in providing real-time data analytics through artificial intelligence to drive operational efficiencies and profitability, is pleased to announce that it has entered into a share purchase agreement (the "SPA") with Passworks to acquire all of the issued and outstanding shares (the "Target Shares") of Passworks S.A. (the "Transaction"), a leading European digital wallet and mobile marketing company with international clients such as luxury fashion leader Hugo Boss, global coupon giant Catalina Marketing Corporation and media giant Wunderman Thompson UK. 

ProMIS Neurosciences to Participate in the Biotech Showcase 2022 Virtual Panel Discussion: Aduhelm Stimulating the Next Generation of Alzheimer’s Treatment

Presswire, 7 January 2022

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in the Biotech Showcase 2022 virtual panel discussion to be held on Jan. 11, 2022 from 8 AM to 9 AM PST.

ProMIS Neurosciences to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference

Presswire, 6 January 2022

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in the H.C. Wainwright BioConnect 2022 Virtual Conference being held January 10–13, 2022.

GLOBAL ROBOTIC PROCESS AUTOMATION CONSULTING FIRM NEOSTELLA EARNS UIPATH DIAMOND PARTNER STATUS

Presswire, 5 January 2022

Neostella, a robotic process automation consulting and development company headquartered in Milwaukee and with additional offices in London, UK; Medellin, Colombia; and Cebu City, Philippines has just earned Diamond Partner status from leading enterprise Robotic Process Automation (RPA) software company, UiPath Inc. (NYSE: PATH). Diamond level is the highest partnership status available to UiPath partners.

Fobi Announces The Signing Of A $300,000 Annual License With Leading Global Insurance Provider To Provide Digital Proof Of Insurance For Europe

Presswire, 5 January 2022

Fobi AI Inc. (FOBI: TSXV FOBIF: OTCQB) (the “Company” or “FOBI”), a leader in providing real-time data analytics through artificial intelligence to drive operational efficiencies and profitability is pleased to announce that the company has signed an annual license with an auto-renewal with one of the world's leading insurance providers. Fobi earns revenue from this deal through an annual license fee as well a license fee per Wallet pass issued, generating monthly recurring revenue.  

Pages

Subscribe to RSS - Americas